News & Events

Jul 10, 2024

ARCALIS exhibit at the 9th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan

We are pleased to announce our participation in the 9th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan to be held at the Sendai International Center from July 15th (Monday) to July 18th (Thursday). Please visit ARCALIS booth and join our corporate seminar during the event.

【Event Details】 

【Booth Information】
 Date: July 15th (Mon.) – 18th (Thu.)
 Venue: Exhibition and Reception Hall “Sakura”

【Corporate Symposium】
 Date: July 17th (Wed.) 11:55 AM – 12:10 PM (C-5)
 Venue: Main Hall
 Title: Process Development and Manufacturing of mRNA Drug Substances
 Presenter: Hiroaki Murakami (CMC Development)
 Abstract: We introduce process development of mRNA drug substances, including case studies on
     improvements in IVT process aimed at reducing dsRNA and development of purification
     techniques. Additionally, we also cover scale-up and GMP production in the factory.

【Poster Presentation】
 Date: July 17th (Wed.) 4:00 PM – 6:00 PM (Even number 5:00 PM – 6:00 PM)
 Venue: Exhibition and Reception Hall “Sakura”
 Poster Number: P3-48
 Title: Analysis of mRNA 5′ Capping Efficiency Using Nuclease P1
 Presenter: Tomohiro Sawadaishi (CMC Development)
 Abstract: In this study, we report a novel analytical method for determining the 5′ capping efficiency
     using nuclease P1. This method facilitates rapid capping analysis and data processing, and
     reveals impurities not identified by the conventional RNase H method. This suggests that our
     method is more precise for evaluating the quality of mRNA therapeutics in terms of capping


Please select the content of your inquiry.